EquityZen Growth Technology Fund LLC - Series 2043
Raised
$419K
Investors
30
Min Invest
$5,001
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2043 is a Delaware pooled investment fund filed by EquityZen Advisors LLC that raised $419K from 30 investors under Rule 506(b) and Section 3(c)(1). The fund requires a $5K minimum investment and is part of EquityZen's pre-IPO investment platform, which operates nearly 1,900 related entities providing access to private growth companies.
This pre-IPO fund utilizes the standard 506(b)/3(c)(1) exemption structure common to private growth equity funds, combining the accredited investor restriction of 506(b) with the 99-investor limit of 3(c)(1). The $5K minimum investment represents an accessible entry point typical of platform-based pre-IPO vehicles designed for accredited retail participation, contrasting with institutional pre-IPO funds that often require six- or seven-figure commitments.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
